- Title
- Venetoclax Treatment Outcomes and Patterns of Use in Relapsed/Refractory Chronic Lymphocytic Leukemia Under Routine Clinical Practice in Saudi Arabia and Gulf Countries (VICTORY Study)
- Creators - without role
- Tarek Abouzeid - Dammam Central HospitalTaimoor Hussain - King Faisal Specialist Hospital & Research CentreSameer AlAmoudi - King Abdullah International Medical Research CenterAhmad Absi - King Saud bin Abdulaziz University for Health SciencesArif Alam - Tawam HospitalMansour Alfayez - King Fahd Medical CityAhmad Alhuraiji - Kuwait Cancer Control CenterMohammed Aldarweesh - King Fahad Specialist HospitalHusni Al-Hateeti - Shaikh Khalifa Medical CityGehad El Ashal - 11RAY Contract Research Organization, Cairo, EgyptOmar Hussein - 11RAY Contract Research Organization, Cairo, EgyptAli Anwar - 12AbbVie Biopharmaceuticals GmbH, Riyadh, Saudi ArabiaMohamed Gouda Ismail - 12AbbVie Biopharmaceuticals GmbH, Riyadh, Saudi ArabiaLeila Bereksi - 13AbbVie SARL, Tunis, TunisiaHaidy Abdellatif - 14AbbVie Biopharmaceuticals GmbH, Dubai, United Arab EmiratesYasser Nour - 14AbbVie Biopharmaceuticals GmbH, Dubai, United Arab EmiratesAbdallah Saad - 12AbbVie Biopharmaceuticals GmbH, Riyadh, Saudi ArabiaNaeem A. Chaudhri - King Faisal Specialist Hospital & Research Centre
- Publication Details
- Blood, Vol.140(Supplement 1), pp.12397-12399
- Publisher
- Elsevier Inc
- Identifiers
- 9913601308331
- Academic Unit
- King Faisal University; Alfaisal University; King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
- Language
- English
- Resource Type
- Journal article
Journal article
Venetoclax Treatment Outcomes and Patterns of Use in Relapsed/Refractory Chronic Lymphocytic Leukemia Under Routine Clinical Practice in Saudi Arabia and Gulf Countries (VICTORY Study)
Blood, Vol.140(Supplement 1), pp.12397-12399
15/11/2022
Metrics
1 Record Views